Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

PRECIOUS-Gold eases as dollar firms, risk appetite gains

Published 11/11/2020, 07:05 PM
Updated 11/11/2020, 09:30 PM
© Reuters.
XAU/USD
-
XAG/USD
-
GC
-
SI
-

* Dollar rises to near one-week high
* Traders eye U.S. initial jobless claims on Nov. 12
* Fed policymakers suggest more specific fiscal support
* Interactive graphic tracking global spread of coronavirus:
https://tmsnrt.rs/3mvcUoa

(Adds analyst comments and updates prices)
By Asha Sistla
Nov 11 (Reuters) - Gold eased on Wednesday on a firmer
dollar and market optimism over a potential COVID-19 vaccine,
but bets for continued monetary support to revive a pandemic hit
economy capped bullion's declines.
Spot gold XAU= fell 0.3% to $1,870.20 per ounce by 1307
GMT, while U.S. gold futures GCv1 slipped 0.4% to $1,868.70.
The dollar, considered a rival safe-haven, rose 0.3% to a
near one-week high, against a basket of currencies. USD/
"The (gold) market is very, very cautious. That's why, the
moment there's news out or the dollar strengthens, the market
goes with it," said Afshin Nabavi, senior vice president at
precious metals trader MKS SA, adding that moves were also
limited by the Veteran's Day holiday in the United States.
"The central banks will need to continue to make money to
throw in the streets so that the system doesn't fall apart... So
until we don't break (below) $1,820, it again feels like gold
may want to test $1,900."
Gold fell as much as 5.2% on Monday after drugmaker Pfizer
PFE.N said its COVID-19 vaccine was more than 90% effective
based on initial trial results, with the resultant optimism
continuing to fuel a strong run in equities. .EU
MKTS/GLOB
But the breakthrough highlighted the logistical challenges
of distributing hundreds of millions of doses once it becomes
available.
The news has slightly reduced the need for stimulus but the
vaccine is not yet available, said Quantitative Commodity
Research analyst Peter Fertig.
Non-yielding gold has risen about 23% so far this year,
supported mainly by near-zero interest rates and unprecedented
global stimulus, since it's considered a hedge against likely
inflation and currency debasement.
Federal Reserve policymakers on Tuesday highlighted the need
for more targeted fiscal support from the government.
Investors now await U.S. weekly jobless claims on Thursday.
Silver XAG= was down 0.3% at $24.14 per ounce. Platinum
XPT= fell 0.5% to $878.84, while palladium XPD= rose 0.2% to
$2,459.61.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.